本科畢業(yè)于北京大學(xué)醫(yī)學(xué)部臨床醫(yī)學(xué)專業(yè)，博士畢業(yè)于北京大學(xué)臨床腫瘤學(xué)院（北京大學(xué)腫瘤醫(yī)院）。曾赴韓國延世大學(xué)世福蘭斯醫(yī)院及意大利圣瑪利醫(yī)院擔(dān)任訪問學(xué)者。研究方向主要為胃腸道惡性腫瘤的外科治療及圍手術(shù)期治療，長期從事胃腸道腫瘤的外科治療，微創(chuàng)手術(shù)經(jīng)驗(yàn)豐富；擅長圍手術(shù)期治療（化療、靶向治療、免疫治療）、胃腸道間質(zhì)瘤及神經(jīng)內(nèi)分泌腫瘤的外科治療及綜合治療。

發(fā)表論文

1. The clinical value and usage of inflammatory and nutritional markers in survival prediction for gastric cancer patients with neoadjuvant chemotherapy and D2 lymphadenectomy. GASTRIC CANCER, 2020. 23(3): p. 540-549.

2. The development and external validation of a nomogram predicting overall survival of gastric cancer patients with inadequate lymph nodes based on an international database. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021. 26(5): p. 867-874.

3. The effect of preoperative treatments on lymph node counts after total gastrectomy in esophagogastric adenocarcinoma. JOURNAL OF SURGICAL ONCOLOGY, 2018. 118(4): p. 657-663.

4. Laparoscopic vs. open lower mediastinal lymphadenectomy for Siewert type II/III adenocarcinoma of esophagogastric junction: An exploratory, observational, prospective, IDEAL stage 2b cohort study (CLASS-10 study). Chin J Cancer Res. 2022 Aug 30; 34: 406–414.